Risk factors in the prediction of long-term patency of Resonance metallic ureteric stent in malignant ureteric obstruction
{{output}}
Objectives: Cancer is the second leading cause of death globally in 2018 with an estimated 9.6 million deaths. The costs of managing malignant ureteric obstruction (MUO) is a significant burden to any healthcare system. However, ... ...
